EYE vs IMM

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

57MEDIUM

IMM

IMMUTEP FPO [IMM]

63MEDIUM-HIGH

Score Breakdown

EYE IMM
Technical
57
69
Catalyst
53
71
Sentiment
50
50
Fundamental
76
93
Momentum
39
42
Risk Gate
45
50

Key Metrics

EYE Metric IMM
$32.8MMarket Cap$81.1M
269KAvg Volume (20d)14.6M
N/AShort Interest+2.4%
$0.20552-Week High$0.470
$0.10052-Week Low$0.028
+0.0%Daily Change-1.8%
$0.115Reference Price$0.055
-42.4%ROE-61.8%
-21.3%Profit MarginN/A

Active Signals

EYE Signals

MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Low P/S ratio (1.0x)
Strong revenue growth (+29%)
EPS estimates revised upward (+10pts)

IMM Signals

MACD momentum is picking up steam
Trading above both moving averages — the trend is your friend here
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (6 quarters)
Moderate P/S ratio (10.2x)
Strong revenue growth (+92%)

Ask Scout AI to compare EYE and IMM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs LDX →EYE vs PNV →EYE vs PTX →EYE vs RHT →EYE vs SOM →
EYE Full Analysis → IMM Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).